Koyfin Home > Directory > Health Care > Aldeyra Therapeu > Total Debt / (EBITDA-CAPEX)

Aldeyra Therapeu Total Debt / (EBITDA-CAPEX) Chart (ALDX)

Aldeyra Therapeu annual/quarterly Total Debt / (EBITDA-CAPEX) from 2012 to 2020.
  • Aldeyra Therapeu Total Debt / (EBITDA-CAPEX) for the quarter ending June 06, 2020 was $-1m a 63.87% decrease of 0m year over year
  • Aldeyra Therapeu Total Debt / (EBITDA-CAPEX) for the last 12 months ending June 06, 2020 was $0m a 13.03% decrease of 0m year over year
  • Aldeyra Therapeu Annual Total Debt / (EBITDA-CAPEX) for 2019 was $0m a 77.35% decrease of 0m from 2018
  • Aldeyra Therapeu Annual Total Debt / (EBITDA-CAPEX) for 2017 was $0m a -18.54% increase of 0m from 2016
  • Aldeyra Therapeu Annual Total Debt / (EBITDA-CAPEX) for 2016 was $0m a -51.66% increase of 0m from 2015
Other Ratios Metrics:
  • Aldeyra Therapeu Total Debt / Capital for the quarter ending September 09, 2018 was $5m a 27.49% increase of 1m year over year
  • Aldeyra Therapeu Other Liabilities for the quarter ending March 03, 2014 was $1m
  • Aldeyra Therapeu Total Debt / Equity for the quarter ending September 09, 2018 was $5m a 28.41% increase of 1m year over year
View Chart On Koyfin

Quarterly ALDX Total Debt / (EBITDA-CAPEX) Data

06/2020$-1m
03/2020$0m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$0m
09/2018$0m
06/2018$0m
03/2018$0m
12/2017$0m

Annual ALDX Total Debt / (EBITDA-CAPEX) Data

2019$0m
2017$0m
2016$0m
2015$0m
2014$0m
2013$0m
2012$0m
2011$-1m